Newsroom

Obesity is one of Qatar’s most pressing public health challenges, affecting more than 70% of the adults and nearly half of all children. The most significant difficulty lies not in losing weight but in maintaining weight loss, a struggle driven by a powerful biological phenomenon: the epigenetic memory of adipocytes (fat cells). This “memory” prompts the body to regain lost weight. 

Recent research indicates that heritable changes in gene expression, specifically epigenetic modifications that do not alter the DNA sequence, play a crucial role in the persistence of obesity and the development of type 2 diabetes (T2D). For Qatar, which faces some of the world’s highest rates of both obesity and diabetes, understanding this challenge is an urgent health priority. 

The Obesity Challenge in Qatar

Qatar faces a unique health landscape. High consanguinity rates (54%), combined with unhealthy lifestyle changes, increase genetic susceptibility, making obesity prevention especially challenging. As a result, the country is seeing a sharp rise in T2D, especially among people with obesity. To tackle this challenge, efforts must go beyond conventional diet and exercise programs and address biological factors that drive weight gain and diabetes. 

For instance, adipose tissue is more than a fat storage site. Fat cells are endocrine regulators that release hormones and signals that affect appetite, metabolism, inflammation, and insulin sensitivity. When a person gains too much weight, these cells become enlarged and stressed, leading to inflammation, mitochondrial dysfunction, and insulin resistance. Most importantly, fat cells retain a “memory” of past eating and metabolic patterns through epigenetic modifications. Even after weight loss, persistent gene changes leave individuals prone to weight gain and metabolic complications. This helps explain why traditional weight loss approaches often fail to produce lasting results.

Epigenetic Memory: the Biology Behind Obesity

Epigenetics is the mechanism behind this cellular memory, involving reversible, heritable changes in how genes work without altering the DNA sequence. In obesity, these mechanisms program fat cells to store fat more efficiently and resist insulin, while turning off genes that help the body burn energy. Even after weight loss, the body can remember its previous obese state and tends to return to it. This explains the high relapse rate after traditional interventions and why obesity is now recognized as a chronic, relapsing condition rather than a short-term disease. 

In Qatar, childhood obesity is common, and the resulting epigenetic changes accelerate the risk of developing early-onset diabetes. While this presents a major public health challenge, it also opens new opportunities. Emerging evidence shows that lifestyle interventions such as regular physical activity and diets rich in anti-inflammatory nutrients can gradually remodel these epigenetic marks, softening the long-term scar of obesity. At the same time, researchers and scientists are developing innovative drug therapies and approaches targeting epigenetic pathways. 

Addressing obesity in Qatar requires a comprehensive strategy. First, lifestyle approaches remain essential but should be designed with an understanding of their epigenetic impact. Second, Qatar’s advanced healthcare system, including resources like the Qatar Biobank, provides a platform for precision medicine approaches, where genetic and epigenetic biomarkers guide personalized interventions. Finally, the most significant long-term benefit will come from prevention, which starts in early life. Since children’s epigenomes are especially malleable, policies that promote maternal health, breastfeeding, and healthy childhood nutrition can help build resilience against obesity and metabolic disease. 

Obesity is not just the accumulation of excess weight; it is an accumulation of epigenetic memory that locks the body into a state of weight gain and metabolic dysfunction. For Qatar, this scientific insight is a powerful call to action. By advancing research into adipocyte epigenetics and integrating these insights into its healthcare system, Qatar can protect its population from the growing burden of disease, set a global example in science-driven healthcare, and invest in the well-being of future generations.

Dr. Olfa Khalifa is a Research Fellow at Hamad Bin Khalifa University’s Qatar Biomedical Research Institute.

The thoughts and views expressed are the author’s own and do not necessarily reflect an official University stance.